ClinicalTrials.Veeva

Menu

Interaction Between Cocaine and Quetiapine - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Unknown
Phase 1

Conditions

Cocaine-Related Disorders

Treatments

Drug: Quetiapine

Study type

Interventional

Funder types

NIH

Identifiers

NCT00087750
NIDA-MDS-0001-1

Details and patient eligibility

About

The purpose of this study is to assess the safety of intravenous (IV) cocaine in subjects taking quetiapine at 3 dosage levels.

Full description

A placebo-controlled, double-blind, inpatient assessment of interaction between intravenous cocaine and quetiapine (seroquel) in cocaine-experienced subjects. To assess the safety of IV cocaine in subjects taking quetiapine at 3 dosage levels.

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Includes but is not limited to: non-treatment seeking individuals. Must meet DSM-IV criteria for cocaine abuse or dependence. Must be able to verbalize understanding of consent and provide written informed consent and verbalize willingness to complete study procedures. Site will provide further details.

Exclusion criteria

Please contact site for further information

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems